Literature DB >> 28078589

Isolation of Lipid Rafts Through Discontinuous Sucrose Gradient Centrifugation and Fas/CD95 Death Receptor Localization in Raft Fractions.

Consuelo Gajate1, Faustino Mollinedo2.   

Abstract

Lipid raft domains, enriched in sphingolipids and cholesterol, serve as sorting platforms and hubs for signal transduction proteins, and show resistance to detergent solubilization. Despite rafts have been involved in survival processes, these membrane domains have also been shown to play a major role in the modulation of death receptor signaling. Here, we describe a detailed protocol for isolating lipid rafts from whole cells by taking advantage of the lipid raft resistance to Triton X-100 solubilization at 4 °C, followed by sucrose gradient centrifugation, with subsequent analysis of Fas/CD95 death receptor localization in the raft fractions by immunoblotting. This method is also useful to localize additional proteins in membrane rafts.

Entities:  

Keywords:  Cell disruption; Cholera toxin B subunit; Death receptor; Detergent-resistant membrane; Fas/CD95; Immunoblotting; Lipid rafts; Sucrose gradient centrifugation; Triton X-100

Mesh:

Substances:

Year:  2017        PMID: 28078589     DOI: 10.1007/978-1-4939-6780-3_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

Review 1.  Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy: Thematic Review Series: Biology of Lipid Rafts.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  J Lipid Res       Date:  2020-11-07       Impact factor: 5.922

Review 2.  Lipid rafts and neurodegeneration: structural and functional roles in physiologic aging and neurodegenerative diseases.

Authors:  Sara Grassi; Paola Giussani; Laura Mauri; Simona Prioni; Sandro Sonnino; Alessandro Prinetti
Journal:  J Lipid Res       Date:  2019-12-23       Impact factor: 5.922

Review 3.  Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  J Lipid Res       Date:  2020-01-27       Impact factor: 5.922

4.  A Single Sphingomyelin Species Promotes Exosomal Release of Endoglin into the Maternal Circulation in Preeclampsia.

Authors:  Leonardo Ermini; Jonathan Ausman; Megan Melland-Smith; Behzad Yeganeh; Alessandro Rolfo; Michael L Litvack; Tullia Todros; Michelle Letarte; Martin Post; Isabella Caniggia
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

5.  Shiga Toxin (Stx)-Binding Glycosphingolipids of Primary Human Renal Cortical Epithelial Cells (pHRCEpiCs) and Stx-Mediated Cytotoxicity.

Authors:  Johanna Detzner; Elisabeth Krojnewski; Gottfried Pohlentz; Daniel Steil; Hans-Ulrich Humpf; Alexander Mellmann; Helge Karch; Johannes Müthing
Journal:  Toxins (Basel)       Date:  2021-02-12       Impact factor: 4.546

Review 6.  Lipid raft involvement in signal transduction in cancer cell survival, cell death and metastasis.

Authors:  Borui Li; Yi Qin; Xianjun Yu; Xiaowu Xu; Wenyan Yu
Journal:  Cell Prolif       Date:  2021-12-22       Impact factor: 6.831

7.  Lipid raft-disrupting miltefosine preferentially induces the death of colorectal cancer stem-like cells.

Authors:  So-Yeon Park; Jee-Heun Kim; Jang-Hyun Choi; Choong-Jae Lee; Won-Jae Lee; Sehoon Park; Zee-Yong Park; Jeong-Heum Baek; Jeong-Seok Nam
Journal:  Clin Transl Med       Date:  2021-11

8.  Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling.

Authors:  Shuiliang Yu; Lei Wang; Danian Che; Mei Zhang; Ming Li; Mikihiko Naito; Wei Xin; Lan Zhou
Journal:  J Exp Clin Cancer Res       Date:  2022-03-08

Review 9.  Mitochondrial Targeting Involving Cholesterol-Rich Lipid Rafts in the Mechanism of Action of the Antitumor Ether Lipid and Alkylphospholipid Analog Edelfosine.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  Pharmaceutics       Date:  2021-05-20       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.